Fluoxetine, the antidepressant commonly known as Prozac, may be beneficial for the treatment of age-related macular degeneration. Researchers found Prozac significantly slowed the rate at which people over 50 developed AMD.
Age-related macular degeneration and lupus share a common contributor to inflammation. The findings could help researchers develop new treatments for those conditions, and other conditions associated with inflammation.
Eating a handful of dried goji berries five times a week may help delay or even prevent the onset of age-related macular degeneration. Over a 90 day period, those who ate goji berries had an increase in protective pigments in their eyes.
Cognitive tests that rely on vision-dependent tasks may skew results for up to 25% of adults over 50 with undiagnosed visual problems such as AMD and cataracts. This may lead to a misdiagnosis of mild cognitive impairment in older adults.
The AREDS2 dietary supplement that substitutes antioxidants lutein and zeaxanthin for beta-carotene reduces the risk of age-related macular degeneration progression, a new study reveals.
A new protocol for differentiating human embryonic stem cells to RPE cells could be a safe and effective approach for treating age-related macular degeneration.
Age-related macular degeneration with subretinal drusenoid deposits was associated with high-risk vascular diseases, including increased stroke risk and cardiovascular disease.
The discovery of new genetic signatures associated with age-related macular degeneration may lead to better diagnosis and treatment of the currently incurable vision disorder.
